piracetam has been researched along with Drug Refractory Epilepsy in 10 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam has a high tolerability and is effective against various seizure types and epilepsy syndromes." | 7.85 | Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy. ( Arakawa, H; Hazama, K; Ida, K; Makioka, N; Motojima, T; Muramatsu, K; Ogata, T; Sawaura, N; Tomita, K, 2017) |
| "A 12-year-old boy with intractable epilepsy had tonic and atonic seizures despite treatment with valproic acid (3000mg/day), levetiracetam (3000mg/day) and clobazam (40mg/day)." | 7.83 | Aggravation of atonic seizures by rufinamide: A case report. ( Aydın, A; Aydınlı, N; Bektaş, G; Çalışkan, M; Özmen, M; Pembegül Yıldız, E; Tatlı, B, 2016) |
| "To assess the efficacy of intravenous (IV) levetiracetam (LEV) in the treatment of status epilepticus (SE) and treatment outcomes." | 7.81 | Intravenous levetiracetam treatment in status epilepticus: A prospective study. ( Atmaca, MM; Bebek, N; Gurses, C; Orhan, EK, 2015) |
| " The point estimates of carbamazepine and lamotrigine efficacy showed their superiority with respect to all comparator antiepileptic drugs for the treatment of newly diagnosed focal epilepsy." | 4.98 | Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis. ( Crescioli, G; De Masi, S; Guerrini, R; Ilvento, L; Lucenteforte, E; McGreevy, KS; Mugelli, A; Pugi, A; Rosati, A; Virgili, G, 2018) |
| "Levetiracetam has a high tolerability and is effective against various seizure types and epilepsy syndromes." | 3.85 | Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy. ( Arakawa, H; Hazama, K; Ida, K; Makioka, N; Motojima, T; Muramatsu, K; Ogata, T; Sawaura, N; Tomita, K, 2017) |
| "A 12-year-old boy with intractable epilepsy had tonic and atonic seizures despite treatment with valproic acid (3000mg/day), levetiracetam (3000mg/day) and clobazam (40mg/day)." | 3.83 | Aggravation of atonic seizures by rufinamide: A case report. ( Aydın, A; Aydınlı, N; Bektaş, G; Çalışkan, M; Özmen, M; Pembegül Yıldız, E; Tatlı, B, 2016) |
| "To assess the efficacy of intravenous (IV) levetiracetam (LEV) in the treatment of status epilepticus (SE) and treatment outcomes." | 3.81 | Intravenous levetiracetam treatment in status epilepticus: A prospective study. ( Atmaca, MM; Bebek, N; Gurses, C; Orhan, EK, 2015) |
| "Nocturnal frontal lobe epilepsy (NFLE) is an idiopathic partial epilepsy with a family history in about 25% of cases, with autosomal dominant inheritance (autosomal dominant NFLE [ADNFLE])." | 1.46 | Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. ( Aroni, S; Marrosu, F; Melis, M; Milioli, G; Muntoni, AL; Parrino, L; Pillolla, G; Pistis, M; Puligheddu, M; Sagheddu, C; Terzano, GM, 2017) |
| "Daytime somnolence was reported by 28 patients, 15 on OXC (10%); 8 received oral modafinil for the same, while none discontinued this AED." | 1.43 | Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy. ( Agarwal, P; Gupta, A; Poornima, S; Shukla, G, 2016) |
| "No correlation between levetiracetam serum levels and clinical efficacy, tolerability or administered dosage was found." | 1.42 | Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy. ( Berkovitch, M; Dagan, Z; Gandelman-Marton, R; Heyman, E; Kohn, E; Sheinberg, R; Youngster, I, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puligheddu, M | 1 |
| Melis, M | 1 |
| Pillolla, G | 1 |
| Milioli, G | 1 |
| Parrino, L | 1 |
| Terzano, GM | 1 |
| Aroni, S | 1 |
| Sagheddu, C | 1 |
| Marrosu, F | 1 |
| Pistis, M | 1 |
| Muntoni, AL | 1 |
| Rosati, A | 1 |
| Ilvento, L | 1 |
| Lucenteforte, E | 1 |
| Pugi, A | 1 |
| Crescioli, G | 1 |
| McGreevy, KS | 1 |
| Virgili, G | 1 |
| Mugelli, A | 1 |
| De Masi, S | 1 |
| Guerrini, R | 1 |
| Sheinberg, R | 1 |
| Heyman, E | 1 |
| Dagan, Z | 1 |
| Youngster, I | 1 |
| Kohn, E | 1 |
| Gandelman-Marton, R | 1 |
| Berkovitch, M | 1 |
| Mateo-Carrasco, H | 1 |
| Serrano-Castro, PJ | 1 |
| Molina-Cuadrado, E | 1 |
| Goodwin, M | 1 |
| Nguyen, TV | 1 |
| Kotecha, PN | 1 |
| Atmaca, MM | 1 |
| Orhan, EK | 1 |
| Bebek, N | 1 |
| Gurses, C | 1 |
| Kato, T | 1 |
| Nakata, M | 1 |
| Ide, M | 1 |
| Saito, K | 1 |
| Yoshida, T | 1 |
| Awaya, T | 1 |
| Heike, T | 1 |
| Chowdhury, A | 1 |
| Brodie, MJ | 1 |
| Bektaş, G | 1 |
| Çalışkan, M | 1 |
| Aydın, A | 1 |
| Pembegül Yıldız, E | 1 |
| Tatlı, B | 1 |
| Aydınlı, N | 1 |
| Özmen, M | 1 |
| Muramatsu, K | 1 |
| Sawaura, N | 1 |
| Ogata, T | 1 |
| Makioka, N | 1 |
| Tomita, K | 1 |
| Motojima, T | 1 |
| Ida, K | 1 |
| Hazama, K | 1 |
| Arakawa, H | 1 |
| Shukla, G | 1 |
| Gupta, A | 1 |
| Agarwal, P | 1 |
| Poornima, S | 1 |
2 reviews available for piracetam and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Carbamazepine; Ch | 2018 |
Role of high-dose levetiracetam as add-on therapy for intractable epilepsy: case report and brief review of the literature.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Drug Synergism; Drug Therapy, Combin | 2015 |
8 other studies available for piracetam and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy.
Topics: Adult; Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Clobazam; Disease Models, Animal; D | 2017 |
Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Databases, Factual; Drug Resistant Epilepsy; F | 2015 |
Intravenous levetiracetam treatment in status epilepticus: A prospective study.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Diazepam; | 2015 |
[Efficacy and tolerability of topiramate, lamotrigine, and levetiracetam in children with refractory epilepsy].
Topics: Adolescent; Anticonvulsants; Child; Drug Resistant Epilepsy; Female; Fructose; Humans; Lamotrigine; | 2015 |
Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Drug Resistant Epilepsy; Female; Follow-Up S | 2016 |
Aggravation of atonic seizures by rufinamide: A case report.
Topics: Anticonvulsants; Benzodiazepines; Brain; Child; Clobazam; Drug Resistant Epilepsy; Drug Therapy, Com | 2016 |
Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Resistant Epilepsy; | 2017 |
Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Disorders of Excessive Somnolence; Drug Re | 2016 |